Glucose Meters

Pharma Supply, Inc. is a family-owned medical device manufacturer and distributor with nearly 25 years of industry experience. The company specializes in home health monitoring solutions, manufacturing and distributing the Advocate®, PetTest®, and Glucose SOS® branded product lines. Primary offerings include blood glucose monitors (notably the Advocate® Redi-Code+ Speaking Blood Glucose Monitor) and blood pressure monitoring systems designed for patient self-management. Products feature bilingual English/Spanish interfaces with audio-guided functionality. The company operates from headquarters in Wellington, Florida, with additional facilities in North Carolina and Puerto Rico, serving approximately 50 countries across North America, Central America, South America, the Caribbean, Europe, Asia, and Africa. Pharma Supply maintains 24/7 multilingual sales and technical support, with a focus on delivering efficient, economical solutions for the medical supply community and end-user patients.

MediVena is a medical device manufacturer specializing in blood collection, injection systems, diagnostics, and personal protective equipment (PPE). The company designs and manufactures a comprehensive portfolio of safety-engineered medical consumables under the MEDIVENA ONE-CARE® brand, including safety lancets (PLUS, PRO, OPTI variants), blood collection winged sets (ERGO-SHIELD, GLIDE & LOCK, PRESS & LOCK), safety syringes, pen needles (PRO DUO, DUO, PRO variants), insulin syringes, and blunt fill needles. In diagnostics, MediVena offers glucose monitors (PRO, BGM-100, Smart Glucose Meter for Connected Health), multimeters, and non-contact infrared thermometers. The company also produces oral syringes, enteral syringes, saline flush syringes, and alcohol prep pads for disinfection. MediVena operates with dual headquarters in Atlanta, Georgia (USA) and Warsaw, Poland, serving acute care facilities, long-term care, physician offices, blood banks, home health, and animal health markets across the United States and international territories. The company maintains best-in-class manufacturing capabilities in the US, Europe, Latin America, and Asia, with emphasis on regulatory compliance and operational excellence. MediVena has received support through the Polish Intelligent Development Operational Programme (2014-2020) for R&D projects focused on innovative safe injection needle technology with minimized dead space, completed during 2021-2023.

KX Medical is an FDA-registered contract manufacturer of single-use, disposable medical devices located in Gallatin, Tennessee. Operating a 30,000 sq ft facility, the company specializes in precision converting and custom medical device manufacturing with 30+ years of industry experience. Core product lines include advanced wound care dressings, continuous glucose monitoring components, remote patient monitoring devices, PPE for patients and caregivers, and IV dressings. The company serves large OEMs and medical device startups with engineering-focused solutions. Manufacturing capabilities include multi-station converting processes up to 13 inches wide with hyper-tight tolerances, inline multi-color flexographic printing, water-based and UV ink processing, Cognex video-controlled registration, Videojet lot coding, and slitting/rewinding services. Equipment includes 9-station and 7-station Delta Flex Crusaders and 16-inch wide 5-color flexographic printing systems. Quality and regulatory credentials include ISO 13485:2016 certification, FDA registration as a contract manufacturer, cGMP compliance, and CFR 820 adherence. UL Registered Firm with Certificate #35765.230523. The company emphasizes strong supplier relationships and custom solutions tailored to customer specifications.

Home Aide Diagnostics, Inc. is a wholesale distributor of medical devices and supplies founded in 2006, serving over 1,000 healthcare partners across 50 US states. The company is NABP-accredited as the first OTC Medical Device Distributor in the nation to achieve this certification, demonstrating commitment to regulatory compliance and quality assurance. Product portfolio spans diabetes care (insulin pen needles, syringes, lancets, lancing devices, blood glucose monitors, test strips), diagnostic and monitoring equipment (blood pressure monitors, thermometers, pulse oximeters), infection control supplies (gloves, alcohol pads), and incontinence aids. All products undergo rigorous testing and quality control before distribution. Home Aide maintains a robust logistics network enabling fast shipping and consistent availability to pharmacies and healthcare facilities. The company operates as a B2B wholesale partner with 500+ products across 15 categories, offering competitive wholesale pricing and serving healthcare providers, pharmacies, and distributors seeking reliable supply chain solutions.

Morepen Laboratories Limited is a diversified Indian pharmaceutical and medical devices manufacturer headquartered in Baddi, Himachal Pradesh, with over 40 years of operational history. The company operates through four primary business segments: Global Generics (Active Pharmaceutical Ingredients), Home Health (home diagnostic products), Dr. Morepen (OTC and healthcare products), and Finished Formulations (generic medicines). The company manufactures and distributes home monitoring devices including blood glucose monitors, blood pressure monitors, nebulizers, thermometers, weighing scales, and steamers. It has an installed base exceeding 14 million glucometers and has sold over 450 million glucose test strips. Morepen holds USFDA approval since 1998 and maintains certifications including WHO GMP, EU GMP, ISO 9001:2005, and ISO 13485:2016 for medical devices manufacturing. The company operates 10 specialized manufacturing plants and exports to over 80 countries. Key product lines include the Dr. Morepen branded glucose monitors and strips with production capacity of 150 million strips and 1 million meters annually, blood pressure monitors, and OTC healthcare products such as Burnol (burns cream) and Lemolate (cough/cold remedy). The company also manufactures active pharmaceutical ingredients, including Montelukast (45 MT annual capacity, world's largest producer), Loratadine (120 MT capacity with over 90% US market share), and Atorvastatin. In the pharmaceutical segment, Morepen serves multispecialty, cardiac, and diabetic categories through dedicated business units with 150+ SKUs. The company has a large domestic distribution network with over 2,000 direct-billed distributors in India and service centers across all four zones.

Acro Biotech, Inc. is a medical diagnostics manufacturer based in Montclair, California, specializing in point-of-care and clinical laboratory testing solutions. The company develops and distributes a diverse portfolio of diagnostic analyzers and rapid testing systems across multiple therapeutic and clinical domains. Product lines include respiratory infection rapid tests (COVID-19 and other respiratory panels, though COVID tests are not FDA-cleared for US distribution), drugs of abuse screening tests, cardiac biomarker assays, urine analyzers, fluorescence immunoassay analyzers, and multiparameter handheld meters for hemoglobin, cholesterol, uric acid, and glucose testing. The company also offers solutions for women's health, infectious disease serology, tumor markers, and veterinary diagnostics. Key analyzer platforms include the ATR-ACO300 urine analyzer, AFR-600 fluorescence immunoassay system (Apoti), AHR-100 multiparameter meter for hemoglobin/cholesterol/uric acid/glucose, and LF Reader systems. The company serves clinical laboratories, point-of-care testing facilities, and veterinary markets with rapid testing and automated laboratory equipment. No specific FDA 510(k) clearances, ISO certifications, or CE Mark designations are stated on the website. Manufacturing capabilities and regulatory status for products marketed outside the US are not detailed in available content.

Rosie Connectivity Solutions is a long-term post-acute care (LTPAC) focused medical equipment and software provider founded in 1977. The company specializes in connected vitals monitoring systems and EHR integration solutions designed to reduce documentation errors, improve nursing workflow efficiency, and enhance patient outcomes in skilled nursing facilities and long-term care environments. Core offerings include the RosieConnectivity platform—a real-time data capture and documentation system that integrates vital signs directly into EHR workflows—and a suite of connected medical devices for point-of-care assessment and monitoring. The company serves skilled nursing facilities, assisted living, and post-acute care providers navigating Medicare/Medicaid reimbursement, infection control requirements, and labor cost pressures. Rosie's product ecosystem addresses common LTPAC pain points: reducing readmissions through continuous vitals monitoring, streamlining compliance documentation, and enabling remote patient assessment capabilities. The platform emphasizes seamless EHR integration to minimize manual data entry and clinical transcription errors. While specific regulatory certifications (FDA 510(k), ISO 13485) are not explicitly stated on the fetched content, the company's focus on connected medical devices and software systems for regulated healthcare environments suggests FDA oversight.

Fresh Test, LLC is a Class II medical device manufacturer specializing in diagnostic glucose beverages for diabetes and gestational diabetes mellitus screening. The company produces a line of natural glucose tolerance test drinks available in 50g, 75g, and 100g formulations, offered in three formats: ready-to-drink bottles, powder-in-a-bottle, and pouches. All products are formulated with three simple ingredients (purified water, non-GMO glucose, organic lemon, and organic mint), free from artificial additives, dyes, and preservatives. The beverages are Non-GMO certified, gluten-free, and packaged in BPA-free containers. Fresh Test products are laboratory-tested for exact glucose equivalency and compliance, with negligible amounts of fructose, sucrose, and fiber. The company maintains a 30-month shelf life and supplies wholesale packaging in 10-unit and 30-unit boxes. Fresh Test holds FDA clearance (3017544399) and operates under ISO 17025 third-party laboratory certification. The company is trusted by leading hospital systems and clinical laboratories nationwide, including HCA, Intermountain Health, Kaiser Permanente, and Medline Industries. Fresh Test offers direct-to-consumer and healthcare provider distribution channels, with clinical resources and a medical advisory board comprising physicians and certified diabetes educators.

Precision Diabetes, Inc. is an emerging leader in precision medicine for diabetes, headquartered in Raleigh, North Carolina (Research Triangle Park). The company develops and markets novel diabetes biomarkers and diagnostic tests that span diabetes risk assessment through complication detection. Primary product is GlycoMark, a proprietary diabetes biomarker test for which Precision Diabetes holds exclusive distribution rights across the United States, Europe, Australia, Asia-Pacific, Middle East, and Mexico. GlycoMark is validated as a prediabetes biomarker and novel indicator of SGLT-2 inhibitor adherence; recent clinical data suggests utility in COVID-19 severity assessment. The company also partners with Patia Europe to distribute DIABETESpredict (type 2 diabetes genetic testing) and Matergen (gestational diabetes genetic testing) in the U.S. market. Precision Diabetes maintains a strategic partnership with DxGen Corp. to commercialize a point-of-care diabetes testing analyzer. The portfolio addresses both clinical laboratory and point-of-care testing modalities, serving endocrinology, primary care, and hospital laboratory markets. Company demonstrates active clinical research engagement, with publications and presentations at major conferences including the American Diabetes Association.

Allison Medical is a manufacturer and distributor of disposable medical supplies and equipment, specializing in diabetes management and animal health products. Founded in 1981, the company offers a comprehensive portfolio including SureComfort™ diabetic products, CarePoint™ precision conventional syringes and needles, CarePoint™ safety-engineered products, CarePoint Vet™ veterinary insulin syringes, and personal protective equipment. The company serves hospitals, clinics, retail/pharmacy chains, and home care markets through its established supply chain and distribution network. Allison Medical also provides OEM/custom manufacturing solutions for medical device partners. With over 35 years of industry experience, the company emphasizes product quality, cost-effectiveness, and innovation through ongoing collaboration with medical professionals and end users to drive improved clinical outcomes.

RENPHO is a global consumer wellness technology brand founded in 2016, headquartered in California with international offices. The company specializes in connected smart health devices and wearables that enable individuals to track and optimize personal health metrics through advanced body composition analysis, vital sign monitoring, and recovery/wellness solutions. Core product categories include smart body composition scales (MorphoScan series using DF-BIA technology), wearable health tracking devices (LYNX smart ring, smart tape measures), eye and foot massage systems, therapeutic massage guns with temperature control, air compression recovery boots, and beauty/aesthetic devices (LED light therapy masks). All devices integrate with RENPHO's free Health App ecosystem, which serves 20M+ users globally with data analytics, goal tracking, and community features. Products are FSA/HSA eligible and clinically validated, with distribution across 100+ countries. The brand targets health-conscious consumers, fitness enthusiasts, and individuals managing chronic health conditions through accessible, app-connected health monitoring technology.

i-SENS USA, Inc. is a US-based distributor and retailer of blood glucose monitoring systems and related diabetes management devices. The company specializes in the CareSens product line, offering multiple glucose meter models including CareSens N, CareSens N Plus (with Bluetooth connectivity), and CareSens N Feliz variants. These meters are designed for diabetic health management, metabolic monitoring, and gestational diabetes screening. The company positions itself as a consumer-direct supplier of glucose monitoring consumables and devices, with educational content on fasting blood sugar, ketone measurement, Glucose Ketone Index (GKI), and dietary management for metabolic health. Products are sold via direct e-commerce with starter kits bundled with test strips. The company serves self-monitoring patients, including those managing prediabetes, Type 2 diabetes, and gestational diabetes mellitus. Regulatory status and certifications are not explicitly stated on the website.

Rasimo Systems is an FDA-listed integrated health technology company specializing in AI-driven digital therapeutics and remote patient monitoring solutions. The company develops the SureMediks® platform, a comprehensive AI-powered digital health ecosystem designed to manage metabolic risk factors including obesity, diabetes, cardiovascular disease, and MASLD. SureMediks integrates connected medical devices (blood pressure monitors, smart scales, glucose meters, ECG wearables, oximeters, CGM systems, and smart rings) with proprietary "Realistic Intelligence" AI to deliver real-time patient monitoring, personalized treatment pathways, lifestyle interventions, and clinical decision support. The platform connects seamlessly to existing EMR systems via standard APIs and includes customizable dashboards for healthcare providers. Rasimo manufactures FDA-compliant medical devices and offers end-to-end solutions including custom device design, medical software development, EMR integration, and HIPAA-compliant telehealth systems. The company also produces AI-enabled hearing aids (BTE, RIC, ITE styles) and wellness platforms (SureFiz Pro). Serves healthcare providers, pharmaceutical companies, insurers, fitness professionals, and enterprise wellness programs.

Movano Health is a wearable medical device company specializing in personalized health monitoring technology. The company develops smart rings and wearable sensors featuring patented radio frequency (RF) technology for non-invasive, cuffless vital sign monitoring including blood pressure, glucose levels, and pulse oximetry. The Evie Ring is designed for women's health with trend tracking and Apple Health integration, while the EvieMED Ring is FDA 510(k)-cleared for clinical-grade pulse oximetry. Movano's proprietary RF chip enables miniaturized, accurate biometric sensing without traditional cuffs or continuous calibration. The company advances clinical validation through partnerships with health researchers and ongoing FDA-regulated clinical studies to expand approved indications for glucose and blood pressure monitoring.

Glooko is a digital health platform specializing in diabetes management and glycemic control. The company operates two primary product lines: the outpatient Glooko Diabetes Management Platform and the inpatient EndoTool Glucose Management System (acquired via Monarch Medical Technologies). The outpatient platform integrates data from over 200 diabetes and health monitoring devices, providing seamless connectivity with continuous glucose monitors (CGMs), blood glucose meters, and wearables. It enables remote patient monitoring, population health management, and secure remote collaboration between patients and care teams through the Glooko Mobile App and clinic dashboard. EndoTool is a patient-specific insulin dosing system designed for hospital inpatient glycemic management, with clinical data showing virtual elimination of severe hypoglycemia. Glooko serves 8,000+ clinics across 30+ countries, providing actionable insights to streamline clinical workflows and improve diabetes outcomes. Clinical evidence demonstrates 18% reduction in average blood glucose within three months and sustained HbA1c improvements. The company maintains robust security and privacy compliance including HITRUST, HIPAA, SOC 2 Type II, ISO 27001, and GDPR certifications, ensuring enterprise-grade data protection for patient health information. Glooko's platform is built on device connectivity standards and interoperability principles to eliminate fragmented data across healthcare systems. The company targets hospitals, health systems, clinics, and individual patients requiring comprehensive diabetes data management and remote monitoring capabilities.

Patients Care Medical Supply is a locally owned durable medical equipment (DME) provider based in Maurice, Louisiana, serving Lafayette and surrounding Acadiana communities. The company supplies a comprehensive range of home health essentials and mobility aids, including hospital beds, power wheelchairs, respiratory therapy products, CPAP equipment, diabetic supplies, wound care materials, patient lifts, and incontinence products. They also offer bracing and support devices, bathroom safety equipment, and lymphedema management solutions. Patients Care Medical Supply accepts Medicare, Medicaid, major insurance plans, FSA/HSA, credit cards, and CareCredit, positioning itself as a patient-centered supplier committed to serving caregivers and patients in the home healthcare market.

Dexcom, Inc. is a leader in continuous glucose monitoring (CGM) systems and glucose biosensing technology, founded in 1999 and headquartered in San Diego, California. The company develops real-time glucose sensing devices that transmit glucose readings directly to smartphones and receivers, enabling people with diabetes to monitor their blood glucose levels continuously and make informed treatment decisions. Dexcom's primary product line includes the Dexcom G7 CGM System and the Dexcom G7 15 Day sensor, designed for adults 18+ with all types of diabetes. The G7 offers best-in-class accuracy and an extended 15-day wear period, with approximately 74% of sensors lasting the full duration. The company also offers Stelo Glucose Biosensor, an over-the-counter (OTC) integrated CGM intended for people 18+ not on insulin, including those with prediabetes or seeking general wellness optimization. Stelo requires no prescription, no fingersticks, and delivers personal glucose insights to users' phones. Dexcom's ecosystem includes connectivity with multiple smart devices and partner integrations to reduce the burden of diabetes management. The company serves patients across multiple insurance channels including commercial, Medicare Advantage, Medicare, Medicaid, VA Health Care, and Kaiser, as well as uninsured/cash-pay patients. Dexcom maintains FDA 510(k) clearance and regulatory compliance for its medical devices and supports healthcare providers through a dedicated provider portal. Manufacturing and distribution capabilities include pharmacy and medical supplier channels.

Sol-Millennium Medical Group is a global healthcare manufacturer and distributor headquartered in Chicago, Illinois, with origins in precision plastic molding dating to 1982. Founded as a medical device company in 2006, Sol-Millennium specializes in design, manufacturing, and distribution of safety-engineered medical devices and personal protective equipment. The company is recognized as one of the world's largest manufacturers of needles and syringes. Product portfolio includes safety-winged infusion sets (Sol-Care™), safety syringes, safety needles, blood collection devices, insulin delivery systems including the InsuJet™ needle-free delivery system, diabetes care products, wound care dressings, and comprehensive PPE offerings. The company maintains a strong global presence with offices in Shanghai, Chicago, São Paulo, and Warsaw, with manufacturing and R&D capabilities distributed across regions. Sol-Millennium is committed to healthcare worker safety through innovation in safety-engineered sharp devices and advancing patient care through high-quality medical consumables.

SiPhox Health is a Burlington, Massachusetts-based health diagnostics company specializing in silicon photonic biosensor technology for at-home blood testing and biomarker analysis. Founded in 2020 and backed by Y Combinator, Khosla Ventures, and Intel Capital, the company has delivered over 300,000 biomarker test results. SiPhox's proprietary EasyDraw kit enables painless upper-arm blood collection without needles or lab visits, with samples processed at CLIA-certified labs. The platform analyzes up to 60 biomarkers across cardiovascular, metabolic, hormonal, thyroid, liver, kidney, inflammation, and nutritional health. Beyond testing, SiPhox provides a centralized health dashboard with wearable integration (Apple Watch, Oura Ring, Fitbit), personalized supplement recommendations, lifestyle coaching, telehealth support, and an AI assistant (Sai) for result interpretation. The company targets chronic disease prevention and health optimization through evidence-based biomarker tracking and actionable insights.

Medisana GmbH is a German medical device and home health specialist founded in 1981, headquartered in Neuss, North Rhine-Westphalia. With over 40 years of expertise, Medisana develops, manufactures, and distributes user-friendly medical devices and wellness products for home healthcare monitoring and personal well-being. The company's portfolio includes blood pressure monitors, blood glucose monitors, TENS/EMS electrotherapy devices, inhalers for respiratory therapy, massage equipment, heating pads, and the VitaDock+ app—an MDR-certified medical device platform for smart vital data monitoring. Products serve allergy relief, cold management, muscle relaxation, and chronic disease management. Medisana maintains WHO-aligned quality standards and compliance with the German Medical Devices Act, serving European and international markets through subsidiaries and licensed partners.

Cambridge Sensors USA, LLC manufactures and distributes the microdot® line of professional blood glucose meters, breath analyzers, and clinical consumables designed for EMS, healthcare providers, and long-term care facilities. The company offers a comprehensive portfolio including blood glucose monitoring systems, safety lancets, disinfection wipes, insulin pen needles, test strips, control solutions, and accessory products. Their offerings serve point-of-care testing in emergency medical services and institutional healthcare settings, with customer support available Monday–Friday, 8 AM–5 PM CST.

SOOIL Development Co., Ltd. is a leading South Korean medical device manufacturer specializing in insulin pump systems and diabetes management solutions. The company develops advanced insulin delivery devices including the Diabecare DANA-i and DANA IIS series, which provide precise subcutaneous insulin administration with integrated blood glucose monitoring capabilities. SOOIL also offers a mobile application for remote diabetes management and patient monitoring. The company combines cutting-edge medical technology with precision engineering to support patients with diabetes care, focusing on improving glycemic control and preventing complications through active insulin therapy. Products are FDA and CE-certified, and the company serves both B2B healthcare institutions and B2C patient markets globally.

GEMCO Medical is a leading national wholesale medical supply distributor and third-party logistics (3PL) fulfillment partner with over 30 years of industry experience. The company specializes in authorized diabetes products, CPAP equipment, and oxygen supplies, serving hospitals, healthcare networks, home medical equipment (HME) providers, and regional healthcare systems nationwide. GEMCO operates multiple distribution centers and provides customized fulfillment services with nationwide delivery capabilities. The company's product portfolio includes Dexcom G7 continuous glucose monitoring systems, Ascensia CONTOUR NEXT GEN blood glucose meters, and their proprietary GEMCORE360° CPAP tubing line. GEMCO functions as an authorized distributor for major diabetes and respiratory manufacturers, offering competitive pricing and drop-ship programs tailored to healthcare facility and retail needs. GEMCO is fully licensed and accredited in all 50 states by the National Association of Boards of Pharmacy (NABP) and maintains HITRUST r2 Risk-Based 2-Year Certification, demonstrating compliance with healthcare data privacy and security standards. The company's compliance infrastructure is supported by its parent company GEMCORE, ensuring adherence to federal, state, and local regulations governing wholesale distribution, third-party logistics, and patient privacy for prescription devices. The organization serves diverse customer segments including national diabetes suppliers, hospital systems, HME providers, and regional healthcare networks, emphasizing personalized service, inventory management, reimbursement optimization, and supply chain efficiency.

Nipro Corporation is a global healthcare company headquartered in Osaka, Japan, with over 70 years of experience serving patients, healthcare professionals, and pharmaceutical companies. The company operates three primary business segments: medical devices, pharmaceuticals, and pharmaceutical packaging. Nipro's medical division is a global market leader in renal care, providing comprehensive dialysis solutions including water treatment systems, dialysis machines, and related disposables. The company also manufactures high-quality disposable medical equipment for hospitals and home care, including needles, syringes, IV sets, and infusion pumps. Nipro's diabetes care portfolio features glucose monitoring systems such as the 4SURE Smart meters. In home infusion therapy, Nipro offers the Surefuser™+ elastomeric infusion pump for ambulatory chemotherapy and drug delivery. The vascular division provides intravascular imaging systems and interventional cardiology tools. Additionally, Nipro manufactures pharmaceutical packaging solutions, including pre-fillable glass syringes and pharmaceutical containers. The company also operates iMEP (Institute for Medical Practice), providing training and education to healthcare professionals globally, and offers infection control solutions including the CLFine environmental disinfection system.

Domrex Pharma is a North American B2B medical device supplier specializing in high-quality consumables and disposable medical supplies. Based in Saint-Eustache, Quebec, the company offers an integrated product portfolio including insulin syringes, safety needles and syringes, blood collection tools, nitrile exam gloves, wound care dressings, safety lancets, and sharps containers. The company operates an e-commerce platform serving hospitals, clinics, pharmacies, and healthcare facilities across Canada and the United States. Domrex Pharma emphasizes cost-effective solutions without compromising quality, competitive pricing, consistent supply chain reliability even during high-demand periods, and customer-focused service for healthcare procurement optimization.

Cliawaived, Inc. is a CLIA-waived medical testing and diagnostic supplies distributor serving clinical labs, physician offices, and home-use markets. The company supplies a broad range of point-of-care (POC) testing products including rapid drug screening tests (drug test cards and cups), infectious disease diagnostics (COVID-19, flu, RSV, mono, strep testing), STD/sexual health testing kits, urinalysis consumables, women's health tests, and general medical supplies. Product portfolio includes analyzers and meter devices (glucose monitors and similar POC analyzers), distributed under partnerships with established manufacturers such as Quidel. The company operates an e-commerce platform enabling B2B procurement of CLIA-waived test kits and supplies for clinical settings and direct-to-consumer home testing products. As a distributor of CLIA-waived diagnostics, Cliawaived serves urgent care centers, physician offices, occupational health programs (workplace drug screening), clinical laboratories, and patients seeking over-the-counter diagnostic testing. All products are CLIA-waived, meeting regulatory thresholds for simple test methodology and low clinical risk. The company maintains inventory of consumables and point-of-care instrumentation to support rapid deployment and same/next-day fulfillment for high-volume testing operations.

Signos is an AI-powered metabolic health platform that combines continuous glucose monitoring (CGM) with personalized weight management guidance for non-diabetic and metabolically-conscious consumers. The platform integrates Dexcom G7 CGM sensors with a proprietary mobile application that uses machine learning to analyze glucose patterns and predict individual metabolic responses to food, exercise, sleep, and stress. Members receive real-time glucose tracking, personalized eating and movement recommendations, registered dietitian support, and weekly metabolic reporting. The service is FDA-cleared and HSA/FSA-eligible, offered through direct consumer channels and employer-sponsored wellness programs. Clinical outcomes show 86% of members report success in their first month, with significant weight loss and improved metabolic stability.

Trividia Health, Inc. is a global diabetes care company based in Fort Lauderdale, Florida, and the largest U.S. manufacturer of store-brand diabetes management products. With over 40 years of industry experience and manufacturing facilities in New Hampshire and Taiwan, the company develops, manufactures, and markets affordable, high-quality blood glucose monitoring systems and diabetes care supplies. Trividia Health's product portfolio includes blood glucose meters, test strips, lancets, insulin syringes, pen needles, glucose tablets and gels, and diagnostic test strips (ketone and A1C). All products emphasize accuracy, convenience, and cost-effectiveness while meeting FDA compliance standards. The company serves major U.S. retailers including Walgreens, CVS, Rite Aid, Walmart, Amazon, Kroger, and numerous regional pharmacies and mail-order providers, ensuring broad access to diabetes care solutions across pharmacy and medical supply distribution channels.

Delta Hi-Tech, Inc. manufactures and markets AIMSCO®, a line of cost-effective diabetes management consumables. The company specializes in insulin syringes, pen needles, lancets, and alcohol prep pads—all positioned as high-quality alternatives to national brands at lower price points. AIMSCO® insulin syringes are available in 28, 29, 30, and 31 gauge options and are latex-free. Pen needles are offered in 29 and 31 gauge; lancets (twist design) in 28, 30, 32, and 33 gauge, engineered to fit most standard lancing devices. Alcohol prep pads are gamma-sterilized, medium-weight, 2-ply spun laced pads supplied in 100 and 200 count boxes. The product line targets pharmacy retailers and individual consumers managing diabetes, offering pharmacies substantial profit margins while delivering consumer savings. All AIMSCO® products emphasize quality parity with leading national brands while maintaining competitive pricing. The company's distribution strategy emphasizes pharmacy partnerships and direct-to-consumer availability.

OneTouch is a leading manufacturer of blood glucose monitoring systems for diabetes self-management. The company produces glucose meters, test strips, lancing devices, and associated consumables for home and point-of-care use. Primary product lines include the OneTouch Verio Flex, OneTouch Ultra 2, and OneTouch Select meters, all featuring ColorSure® Dynamic Range Indicator technology that visually indicates whether readings fall within the user's personal target range. OneTouch also offers the OneTouch Reveal® mobile and web application for seamless glucose data logging, tracking, and sharing with healthcare providers. The meters integrate Bluetooth connectivity for smartphone synchronization and A1c trend analysis. OneTouch is marketed as the #1 doctor-recommended meter brand and serves millions of patients with Type 1 and Type 2 diabetes. Products are available through direct consumer purchase, subscription-based supply ordering, and healthcare provider networks. The company provides comprehensive customer support including technical troubleshooting, logbook downloads, control solution ordering, and lancet replenishment. Regulatory compliance includes FDA clearance for all glucose meter systems and associated consumables. Manufacturing and distribution operate under standard medical device quality management systems.

MHC Medical Products designs and manufactures high-quality medical products for human and animal healthcare, with primary focus on diabetic care, clinical supplies, and diagnostic devices. The company operates five main product lines under the EasyTouch and SureLife brands, distributed through leading US medical wholesalers and neighborhood pharmacies. EasyTouch Insulin Syringes and glucose monitoring devices serve diabetic patients; EasyTouch Clinical Care includes safety syringes, pen needles, and lancets (25+ SKUs). SureLife offers blood pressure monitors and pulse oximeters for home monitoring. EasyTouch Vet provides U-40 insulin syringes and glucose monitors for veterinary/animal health applications. ColorSafe delivers pharmaceutical vials and ovals in five color options for prescription organization and personalization in pharmacy settings. Products are positioned as quality alternatives to national leading brands with emphasis on ease of use, accuracy, and value. Distribution network includes America's leading medical wholesalers. The company emphasizes manufacturing quality and user experience across consumer diabetic and medical product categories.

i-SENS is a global biotechnology company headquartered in South Korea and operating in over 110 countries, including the United States and Europe. The company is the market leader in Korea's blood glucose monitoring device market and specializes in blood glucose management systems, continuous glucose monitoring (CGM) systems, in vitro diagnostics (IVD), and veterinary diagnostic solutions. i-SENS manufactures the CareSens line of self-monitoring blood glucose systems, which meets ISO 15197:2013 accuracy standards for hematocrit and interference criteria. The CareSens Air continuous glucose monitoring system is the first domestically produced CGM in Korea with CE certification, providing real-time glucose data and trend analysis for diabetes management. The company's IVD System leverages whole blood-based diagnostic technology for point-of-care testing applications. i-SENS operates with an annual production capacity of 2.1 billion blood glucose test strips, supporting millions of patients globally. The company maintains regulatory compliance with FDA and CE certification standards. Recent partnerships include a transformational collaboration with LifeScan to launch the OneTouch® Continuous Glucose Monitoring System, leveraging i-SENS technology. The company serves healthcare systems, diabetes management clinics, point-of-care diagnostic facilities, and veterinary care providers. i-SENS is committed to advancing diabetes care innovation and expanding access to glucose monitoring solutions worldwide.

ForaCare Inc. is a healthcare technology company specializing in chronic disease management through integrated medical devices and telehealth software. The company designs and manufactures blood glucose monitors, blood pressure monitors, pulse oximeters, nebulizers, wireless weight scales, and Bluetooth thermometers for diabetes, hypertension, COPD, and chronic heart failure management. All devices connect via cellular or Bluetooth to the proprietary FORA® 24/7 HealthView Telehealth System, a HIPAA-compliant cloud platform that enables real-time remote patient monitoring and physician access to patient data. ForaCare also offers iFORA mobile applications available on iOS and Google Play for patient engagement and chronic disease self-management. The company manufactures and designs products with an emphasis on accuracy, ease of use, and clinical validation. Primary markets include remote patient monitoring programs for chronic disease management across diabetes care, hypertension management, respiratory care, and weight management. The FORA 24/7 HealthView System serves as the central integration hub connecting all wireless medical devices to a telehealth gateway for comprehensive remote monitoring. ForaCare operates with a global customer base and maintains design and manufacturing capabilities.

Oak Tree Health is a diabetes care manufacturer specializing in blood glucose monitoring systems for individual patients, long-term care facilities, and managed care organizations. The company operates manufacturing and service facilities in Asia and the United States, with a customer service call center supporting both US and international markets. Their primary product line is the EasyMax® series of glucose meters, which includes models designed for accessibility (low-vision users), standard daily management, long-term care environments, and emerging type 1 diabetes solutions. The EasyMax® V features audible results for visually impaired users; the EasyMax® NG offers a modern interface with clear display; the EasyMax® V2 provides compact, quick readings; and the EasyMax® LTC is optimized for long-term care settings with 3-button operation and alternate site testing capability. Oak Tree Health indicates forthcoming products in diabetes foot ulcer monitoring (DFU), affordable care meters (ACM), and probiotics. The company positions itself as offering competitive bidding, co-branding, and telemedicine integration services for healthcare systems and managed care providers. Manufacturing and service capabilities span global operations with emphasis on rapid cycle time and dual-market support (Asia and North America).

Senseonics, Inc. is a publicly traded medical device company headquartered in Germantown, Maryland, specializing in continuous glucose monitoring (CGM) systems for diabetes management. The company manufactures and markets the Eversense system, the first and only long-term implantable continuous glucose monitoring device. The Eversense CGM system features a subcutaneous glucose sensor designed for extended wear periods, including a 180-day implantable version and a next-generation 365-day implantable variant. The company's products are distributed through partnerships, including Ascensia Diabetes Care for select markets. Senseonics supports its systems with clinical evidence demonstrating improved glycemic control in CGM-naive patients, validated through clinical studies including the PROMISE and ENHANCE trials. The company maintains robust regulatory compliance with FDA clearance for its implantable glucose monitoring technology. Senseonics serves endocrinologists, diabetes educators, and hospital-based diabetes management programs across the United States and international markets, positioning itself as a leader in long-acting implantable CGM technology differentiated from traditional wearable glucose monitoring alternatives.

LS & S, LLC is a Buffalo, NY-based retailer specializing in assistive devices and adaptive products for individuals with vision loss, hearing loss, and deaf-blind conditions. The company operates an extensive e-commerce platform offering low-vision aids, hearing helpers, daily living aids, and adaptive technology designed to support independence. Product lines include electronic magnifiers (desktop CCTVs, portable handheld units, wearable technology with OCR capabilities), optical magnifiers (stand magnifiers, handheld LED magnifiers, monoculars, binoculars), specialized lighting (daylight lamps, task lighting, magnifying lamps), talking devices (clocks, watches, scales, glucose meters, blood pressure monitors, thermometers), braille products (watches, household items, writing tools), mobility aids (Ambutech canes, support canes), alerting systems for deaf and hard-of-hearing users (Silent Call, Sonic Alert, Clarity, Serene), amplification devices (personal amplifiers, FM systems, TV listening systems), and hearing aid accessories. Additional offerings include educational materials, games adapted for low vision, healthcare monitoring products, telephones for visually and hearing-impaired users, and memory care products. The company distributes brands including NoIR Medical, Schweizer, Walters, Ambutech, and others. LS & S serves the low-vision, deaf, hard-of-hearing, and adaptive living markets through direct online sales with free shipping on orders over $75.

GEMCORE is a family of companies specializing in comprehensive diabetes management and chronic disease support solutions for over 30 years. The organization operates through five integrated divisions: EHCS (mail-order supplies including CGMs, insulin pumps, breast pumps, and diabetes testing supplies), GEMCO (medical supply distribution and third-party logistics for diabetes, wound care, and respiratory products), GEMCARE (health coaching and disease management programs led by registered dietitians), and GEM RX (mail-order pharmacy dispensing brand-name, generic, and compounded medications). GEMCORE serves patients, payers, and healthcare organizations by reducing costs and improving patient outcomes through customized, scalable solutions. The company is based in Hudson, Ohio, and has been recognized multiple times as one of Cleveland's fastest-growing companies and a top workplace in Northeast Ohio. Primary service model includes direct-to-home delivery, personalized disease management programs, nutritional guidance, and integrated pharmacy and supply services. Target markets include patients with diabetes and chronic conditions requiring ongoing medication and supply management.

Phoenix Healthcare Solutions, LLC is a medical device and home healthcare manufacturing company headquartered in Fort Lauderdale, Florida, with manufacturing operations in Mumbai, India. Since 2011, the company has specialized in custom design and manufacturing of sterile medical consumables, home healthcare products, mother and baby care items, and personal care products for domestic and global markets. Core product lines include safety lancets (Bullseye brand), blood lancets (AquaLance brand), sterile alcohol prep pads, digital thermometers, air mattresses, steam vaporizers, lens cleaning wipes, and lancing devices. The company offers comprehensive end-to-end manufacturing services including research and development, design and prototyping, injection molding, quality assurance testing, custom packaging, and regulatory compliance support. Manufacturing capabilities span concept design through final production and shipment with in-house analytical, QC, and R&D laboratories. Phoenix holds certifications including FDA approval, ISO 13485, CE certification (Europe), ANVISA (Brazil), INVIMA (Colombia), UKCA (United Kingdom), CDSCO and Indian FDA (India), MHRA (UK), and SMETA audit certification. The company serves Fortune 500 global companies and maintains relationships with 50+ small-to-medium medical and surgical distributors throughout the US and worldwide. OEM and private-label manufacturing services are available.

AOA Medical is a wholesale medical supplies and equipment distributor serving hospitals, clinics, senior centers, and assisted living facilities. The company supplies a comprehensive catalog of health monitoring devices, postoperative medical essentials, mobility aids, and wound care products sourced from leading manufacturers. Primary product lines include blood glucose monitoring systems, blood pressure monitors, orthopedic support devices (inflatable walker boots, gait belts), and postoperative wound management supplies including silicone scar tape. Beyond equipment distribution, AOA Medical offers corporate wellness programs and on-site health monitoring services to businesses of all sizes, including chair massage events, yoga and meditation sessions, and employee health screening services (blood pressure, glucose, and pulse monitoring). The company positions itself as a trusted partner for healthcare institutions and businesses seeking to improve patient outcomes and employee well-being. Services include wellness program consultation, custom program development, and on-site delivery of wellness initiatives. Target markets span institutional healthcare providers and corporate employers seeking proactive health management solutions.

Altek Biotechnology Corporation is a leading digital imaging technology contract manufacturer (CDMO) specializing in OEM and ODM services for medical device brand companies. The company holds market-leading positions as the worldwide No. 1 BGM (blood glucose meter) CDMO and the worldwide No. 1 single-use endoscope CDMO. Core product categories include glucose meters, single-use (disposable) endoscopes, and intelligent insulin delivery systems. Altek offers comprehensive capabilities spanning the full product development lifecycle: concept development, R&D engineering, prototyping, product development, manufacturing, quality assurance, and process automation. The company specializes in miniaturization and digital imaging technologies, enabling manufacturers to bring innovative point-of-care and home-use diagnostic devices to market. With established long-term partnerships with tier-one global medical brands, Altek provides turnkey solutions from initial concept through mass production, emphasizing superior manufacturing processes, regulatory compliance, and product optimization. The company leverages expertise in automation and quality assurance to explore hidden compliance risks beyond baseline conformity requirements.

PTS Diagnostics is a manufacturer of point-of-care diagnostic testing systems specializing in lipid panel, blood glucose, and A1C testing. The company designs portable, battery-powered analyzers intended for deployment across diverse clinical settings including physician offices, pharmacies, mobile health clinics, hospitals, universities, workplaces, and home settings. Their core products—CardioChek® for lipid testing and A1CNow® for A1C measurement—deliver test results in minutes using CLIA-waived methodology. Test strips and cartridges operate at room temperature without refrigeration requirements. All analyzers meet national standards for accuracy and precision. PTS Diagnostics also manufactures the PTS Connect® family of data management products (Blu-Adapter, Blu-Dock, Printer) enabling integration and result sharing across healthcare environments. The company positions its solutions for accessibility in diabetes management, cardiovascular disease risk assessment, self-testing, home health services, community health programs, occupational health screening, and pediatric applications. Products are designed for minimal storage footprint and lightweight portability. The company provides online training and direct customer support, operating Monday–Friday, 8 a.m.–8 p.m. EST.

Gojji is a chronic disease management platform that delivers remote monitoring and personalized care support for patients with diabetes, hypertension, high cholesterol, and related conditions. The company operates a whole-person care and population health program aligned with payors and primary care providers to bridge gaps between clinical visits. Gojji's service model includes real-time glucose monitoring via personal meters, telephonic care coordination, dietary guidance, medication management, and continuous health tracking accessible through a patient portal. The platform integrates with healthcare systems and supports multiple chronic disease prevention programs including diabetes prevention, obesity/weight management, and asthma/COPD management. Gojji serves community health centers, federally qualified health centers (FQHCs), and health plans across California, with particular strength in Medi-Cal populations. The company provides multilingual support (12+ languages) and operates business hours Monday–Friday, 8:00 AM–6:00 PM. Patient testimonials emphasize improved blood sugar control and empowered self-management through frequent monitoring and personalized coaching. Gojji's clinical model emphasizes individualized experiences, real-time data visibility, and collaborative care between patients, primary care physicians, specialists, and payors to shift populations toward improved health outcomes.

Abbott is a global healthcare company headquartered in Abbott Park, Illinois, serving approximately 2 billion people worldwide with life-changing technology across diagnostics, medical devices, nutrition, and pharmaceuticals. The company manufactures and distributes a diverse portfolio of medical diagnostic equipment, devices, and consumer health products. Notable product lines include the Lingo Glucose System for continuous glucose monitoring in non-insulin users, advanced cancer testing and diagnostics solutions (including Exact Sciences partnership), cardiac monitoring systems, and point-of-care diagnostic equipment. Abbott operates across multiple therapeutic areas including cardiology, oncology, diagnostics, and nutrition. The company maintains FDA 510(k) clearances and CE marking for various medical devices and diagnostic platforms. Abbott distributes products globally through direct sales, healthcare partnerships, and retail channels, with significant presence in hospital systems, clinical laboratories, and home-care settings. The organization emphasizes innovation in precision diagnostics, digital health integration, and patient monitoring technologies.

Laboratory Corporation of America Holdings (Labcorp) is a global leader in laboratory services headquartered in Burlington, North Carolina. Operating in approximately 100 countries with over 70,000 employees, Labcorp performs more than 700 million tests annually and generates $13.01 billion in revenue. The company provides comprehensive clinical diagnostics, drug development support, and specialized testing including oncology, rare diseases, and genomic sequencing. Labcorp's integrated platform connects diagnostics to biopharma development, supporting healthcare providers, researchers, and investigators. Key offerings include AI-powered diagnostic assistance tools, real-world data platforms for drug development, genetic testing services (including Invitae), nonclinical research, central laboratory services, and clinical trial support. The company serves patients, healthcare providers, health systems, managed care organizations, and biopharmaceutical companies. Over 75% of new drugs approved by the FDA have been supported by Labcorp's services.

HealthSmart International (DMS Holdings) is a multi-brand distributor and manufacturer of home medical devices, mobility aids, and personal health monitoring equipment. The company operates a portfolio of established medical product brands including MABIS®, DMI®, Heelbo®, Switch Sticks®, Brazos®, and Steins®. Product offerings span blood pressure monitors (digital and manual sphygmomanometers), fingertip pulse oximeters, digital thermometers, compression sleeves and support garments, mobility and walking aids (canes, walkers, rollators), rehabilitation and positioning pillows/cushions, heel/elbow/ankle support products, bath safety equipment, foot care solutions, home air purification systems, and wellness accessories. MABIS® is a manufacturer established since 1992 specializing in precision diagnostic instruments; DMI® offers comprehensive rehab and positioning solutions; Heelbo® focuses on breathable compression and support products; and Steins® is noted as an 80+ year authority in American-made foot care. The company markets medical-grade consumer and professional healthcare products for home use, senior care, mobility assistance, and post-operative recovery. Distribution channels include direct e-commerce through livehealthsmart.com and B2B medical supply channels. Products emphasize clinical accuracy, durability, and affordability for homecare and personal health management markets.

Prodigy Diabetes Care, LLC is a manufacturer of blood glucose monitoring systems and diabetes management products. The company specializes in innovative glucose meters designed for home and clinical use, including talking meters (AFB/NFB award-winning), multilingual models (four-language support), and interchangeable test strip platforms compatible across multiple meter models. Prodigy's product line includes the PRODIGY AutoCode® and PRODIGY Pocket® meters. The company also develops companion software for data management, scheduling, target setting, reporting, graphing, and result tracking. Products are distributed through healthcare distributors to patients and healthcare providers. The company maintains a professionally trained customer care team providing technical support, warranty activation, and product troubleshooting. Prodigy's mission is to establish standards of excellence in blood glucose monitoring systems and encourage people with diabetes to live well with their condition. The company operates in the home diabetes monitoring segment, serving individuals requiring regular glucose monitoring.

Withings is a leading French connected health company founded in 2008, specializing in consumer-grade medical devices that combine clinical accuracy with elegant design. The company manufactures and distributes a comprehensive ecosystem of FDA-cleared and clinically validated health monitoring devices including smart scales with body composition analysis, hybrid smartwatches with built-in ECG and cardiac monitoring capabilities, connected blood pressure monitors, sleep tracking systems, and innovative devices like Body Scan (advanced body composition analysis), U-Scan (toilet-embedded urine analysis), and BeamO (portable home health station). All products integrate with the Withings Health Mate app and cloud platform for continuous health data aggregation and insights. Withings serves both B2C consumers and B2B healthcare providers globally through Withings Health Solutions, enabling remote patient monitoring, clinical research, and population health management. The company operates offices in Issy-les-Moulineaux (France), Boston, and Hong Kong, serving over 40 countries with devices recognized for medical-grade accuracy and accessibility.

SteriLance Medical (USA) Inc., founded in 1993, is a precision medical device manufacturer specializing in diabetes care consumables and clinical blood collection products. The company designs, manufactures, and distributes a comprehensive product portfolio including safety lancets, lancing devices, insulin pen needles, and specialized blood sampling instruments for glucose monitoring. Their product lines serve diabetic self-care and clinical laboratory applications. SteriLance also manufactures surgical blades (disposable safety scalpels) and alcohol preparation pads for clinical and procedural use. The company operates manufacturing facilities in China (Suzhou) with a US operational base in Duluth, Georgia, serving a global distribution network including prominent domestic and international blood glucose meter manufacturers. The company emphasizes user safety, comfort, and functionality in product design. SteriLance maintains quality certifications and regulatory compliance standards appropriate to medical device manufacturing. The firm participates regularly in international medical trade exhibitions (MEDICA, CMEF, Medlab) and maintains active partnerships with leading glucose meter manufacturers worldwide.

Ascensia Diabetes Care is a global medical device company specializing in blood glucose monitoring systems and diabetes management solutions. The company's primary product portfolio centers on the CONTOUR® brand of blood glucose monitoring systems, which are designed to provide advanced accuracy and user-friendly functionality for patients managing diabetes. The CONTOUR® NEXT line represents their flagship offering, featuring advanced technology for reliable glucose measurement and data tracking. In addition to hardware monitoring devices, Ascensia offers integrated diabetes management solutions that enable patients to track results and monitor trends over time. The company operates as a global organization with local market presence through regional websites and distributors. Ascensia is part of the PHC Group, which has implemented a comprehensive ESG (environmental, social, and governance) strategy aligned with global sustainability goals. The company is committed to innovation in diabetes care and serves patients through both consumer-facing products and healthcare provider channels. Their manufacturing and regulatory compliance aligns with international standards for in vitro diagnostic devices used in point-of-care glucose monitoring applications.

Tidepool is a digital health platform that aggregates and visualizes diabetes management data from multiple device manufacturers into a unified, cloud-based system. The company provides software solutions for patients, caregivers, and healthcare providers to securely upload, access, and analyze continuous glucose monitoring (CGM) data, insulin pump data, and blood glucose meter readings from devices manufactured by Medtronic, Tandem, Omnipod, Dexcom, Abbott FreeStyle Libre, and numerous other diabetes device makers. Tidepool offers three primary software products: Tidepool Uploader (desktop application for data synchronization), Tidepool Mobile (patient-facing app for device pairing and data review), and Tidepool Data Platform with a Population Health Dashboard for healthcare provider insights. The company also develops Tidepool Loop, a closed-loop automated insulin delivery system derived from the open-source Loop community, distributed commercially by Sequel Medical Technologies as twiist Loop. Tidepool serves patients managing type 1 and type 2 diabetes, healthcare providers including endocrinologists and primary care physicians, telemedicine platforms, and diabetes researchers. The platform integrates real-time data from 40+ compatible devices and emphasizes accessible, actionable insights to improve glycemic control and reduce diabetes management burden. Tidepool supports HIPAA-compliant data sharing and serves the US market with focus on accessibility and interoperability across the diabetes device ecosystem.

ACON Laboratories, Inc. is a US FDA-registered global medical device manufacturer specializing in point-of-care testing (POCT) and immunoassay products. Headquartered in San Diego, California, the company develops and manufactures diagnostic solutions across four primary product lines: Point of Care, Immunoassays, Molecular Diagnostics, and Animal Health. Products serve hospitals, clinical laboratories, physician offices, blood banks, pharmacies, and veterinary clinics worldwide. The On Call® Blood Glucose Meter Family is designed for glucose monitoring and diabetes management. Mission® brand includes urine reagent test strips, urine analyzers, and handheld devices for cholesterol, coagulation, and hemoglobin measurement. HealthyMe® provides urinary tract infection (UTI) detection reagent strips. Flow flex® is the newest lateral flow rapid testing brand, offering multiplexed home tests including the recently FDA 510(k)-cleared Flow flex® Plus RSV + Flu A/B + COVID multiplex rapid antigen test for ages 6 months and up. The company's ACON brand offers lateral flow rapid tests for pregnancy, cancer markers, and infectious disease screening, including SARS-CoV-2 antibody and antigen tests. Distinct® provides pregnancy rapid tests using qualitative chromatographic immunoassays. Foresight® offers allergen immunoblot testing for 30 allergens on a single strip. Promotor® provides nucleic acid extraction systems and PCR quantitative test kits for HBV, HCV, HPV 16/18, HPV genotyping, tuberculosis, and HLA-B27. CentriVet® serves veterinary diagnostics with dual ketone/glucose meters and urine reagent strips. ACON maintains US FDA registration, provides contract manufacturing and OEM services, and holds multiple FDA 510(k) clearances for its diagnostic products.

BiometerPlus USA, Inc. manufactures electrochemical biosensor-based handheld diagnostic meters for home and clinical self-testing. The company's primary product line uses advanced electrochemical technology to measure glucose, total cholesterol, HDL, LDL, and triglyceride levels from capillary blood samples (10 µL). Devices feature built-in strip identification, battery-powered operation (2 AAA batteries), wireless connectivity capability, and results display within 30 seconds. The meters are designed for ease of use with minimal, intuitive design incorporating LED indicators, setup buttons, and dedicated testing strip slots. Products support self-management applications in chronic disease monitoring, particularly diabetes and lipid panel testing in home care settings. The company emphasizes energy efficiency, superior industrial design, and high compatibility across testing strip types. Target markets include individual consumers, home healthcare providers, and clinical settings requiring point-of-care diagnostics.

Tianjin Empecs Medical Device Co., Ltd. is a Chinese manufacturer and supplier of blood glucose monitoring systems, acupuncture products, and diabetes care consumables. Founded in 1992 and formerly known as Tianjin Haing Lim Sou Won Medical Instrument Co., Ltd., the company has expanded from acupuncture needle manufacturing to biosensor technology for glucose monitoring. The company operates manufacturing facilities in Tianjin, China, and a Korea R&D center, with a U.S. branch established in 2003. Product portfolio includes no-coding and smart blood glucose meters (Medisign MM800, MM200, MM600, MM1000, MM1100, MM1200 series), blood glucose test strips (0.5µL sample volume), lancing devices, sterile and pre-loaded acupuncture needles, moxibustion products (sticks, blocks, pipes), and silicon cupping sets. The company holds FDA 510(k) clearance for blood glucose monitoring systems in the U.S. market, CE Mark certification in Europe, SFDA approval in China, and KFDA approval in Korea. Products are exported to Europe, America, Africa, and Asia. Manufacturing capacity of 5,000–10,000 square meters with 301–500 employees. The company markets products with an emphasis on affordable diabetes care and accessible pricing for patients in developing regions.

Diathrive, Inc. is an enterprise diabetes and metabolic health management platform serving organizations and employers. The company provides integrated solutions for diabetes care, continuous glucose monitoring (CGM), and GLP-1 weight management programs. Diathrive's service model combines unlimited medical supplies (lancets, testing devices), clinical support from registered nurses and certified diabetes care and education specialists (CDCES), and data-driven care coordination. The platform enables employers to optimize employee health outcomes while managing program costs through physician oversight, personalized support protocols, and ROI-focused monitoring. Services include Health Advisor support for scalable workforce wellness coaching, CGM cost control and utilization optimization, and comprehensive GLP-1 pharmacotherapy programs with clinical governance. The company targets large organizations seeking to reduce diabetes-related healthcare costs and improve employee productivity through evidence-based protocols and continuous remote monitoring.

Valmar Surgical Supplies is a home healthcare DME (durable medical equipment) distributor serving patients across the Northeast. Leveraging deep industry expertise and compassionate customer support, the company supplies mobility aids, respiratory therapy equipment, diabetic management supplies, and pressure ulcer prevention devices for home use. Valmar Surgical manages insurance authorizations, conducts clinical assessments to meet Medicare/payor requirements (WOPD, face-to-face exams), and provides next-day delivery. The company specializes in equipment selection counseling, ensuring patients receive products appropriate for their specific conditions and coverage eligibility. Services include detailed documentation support for enteral feeding, oxygen therapy, CPAP, orthotic and prosthetic devices, and post-operative support surfaces.

iHealth Labs Inc is a leader in consumer and clinical-grade home health monitoring devices founded in 2010. The company manufactures and distributes wireless vitals monitoring systems, rapid diagnostic tests, and telehealth-integrated solutions for patient self-management and remote patient monitoring (RPM). Product portfolio includes blood pressure monitors (Neo, Track Pro, 550BT models), wireless glucose monitors (Gluco+ system), pulse oximeters (Air Pulse), digital and infrared thermometers (PT1, PT3, PT5), and rapid diagnostic tests for COVID-19, influenza A/B detection. iHealth devices feature Bluetooth connectivity, cloud-based app integration (iHealth MyVitals), and clinical validation. The company holds FDA authorization for rapid test kits and has supplied millions of COVID-19 tests to the U.S. federal government. iHealth also operates iHealth Unified Care, a remote patient monitoring platform enabling Chronic Care Management (CCM) and RPM billing for healthcare providers. Products are FSA/HSA-eligible and sold direct-to-consumer and through healthcare systems. The company serves homecare, chronic disease management, and provider-based RPM markets with emphasis on ease of use, wireless connectivity, and integration with EHR/digital health workflows.

Freedom Medical Wholesales Inc. is a medical wholesaler and distributor serving pharmacies, clinics, and healthcare suppliers across Puerto Rico and the Virgin Islands. With over 20 years of experience, the company specializes in diabetes care products including glucose meters, test strips, insulin syringes, and lancets. Product portfolio also includes orthopedic supports (knee, wrist, ankle, back, and lumbar braces), respiratory care devices (compressor nebulizers), protective supplies (face masks, disposable gloves, nitrile gloves, alcohol swabs, disinfection solutions, first-aid and wound-care items, and PPE kits), and pediatric orthopedic supports (My Prim Kids line covering thumb immobilizers, wrist immobilizers, elbow supports, ankle supports, clavicle immobilizers, sacrolumbar belts, knee immobilizers, knee braces, shoulder immobilizer straps, slings, and wraparound wristbands). The company operates a B2B e-commerce platform offering flexible payment options (cash, checks, ACH transfers), free shipping on orders above $200, a 15-day return policy, and localized delivery within 24–48 hours. Regulatory certifications and manufacturing standards not explicitly stated on website.

UniStrip Technologies, LLC manufactures and distributes generic blood glucose test strips under the TruePoint and UNISTRIP brand names. The company specializes in glucose monitoring consumables designed as compatible alternatives to proprietary OneTouch test strips. TruePoint test strips utilize glucose oxidase technology and are compatible with multiple OneTouch meter models including Ultra, UltraMini, Ultra 2, and UltraSmart. The company markets its products as providing safer and more accurate results compared to branded alternatives. UniStrip serves the home diabetes management and personal medical device market, targeting patients and healthcare systems seeking cost-effective glucose monitoring supplies. Distribution channels include retail and direct-to-consumer purchase options. The company positions itself as a supplier of generic diabetes care consumables for the homecare market.

Metene Limited is a global homecare and personal medical device manufacturer specializing in blood glucose monitoring systems and vital signs monitoring devices. The company claims to be the world's No. 1 blood glucose monitor brand, with products sold in 58 countries and over 60 million units distributed worldwide. Metene's primary product line comprises blood glucose meters (TD-4116 and AGM-513S models), compatible test strips, and lancing devices designed for diabetics, elderly patients, pregnant women, and individuals at risk of diabetes. Key product features include rapid 5–7 second readings, minimal blood sample requirements (0.5–0.7 μL), no-coding convenience, data storage, and reminder alarms. The company also manufactures fingertip pulse oximeters (SpO2 monitors) and no-touch thermometers. Metene devices utilize advanced biosensor technologies including Glucose Dehydrogenase (FAD-GDH) enzymes and 99.99% gold electrodes to minimize interference and temperature/humidity deviation. Products are marketed as suitable for home and consumer use rather than clinical/hospital settings. The company operates a direct-to-consumer e-commerce platform (metene.com) with educational content on diabetes management and blood glucose monitoring. While the site emphasizes consumer accessibility and ease of use, specific regulatory certifications (FDA 510(k), CE marking, ISO 13485) are not explicitly mentioned in the fetched content. Manufacturing location and quality certifications remain undisclosed on the primary website.

Thirdwayv is an IoT connectivity and cybersecurity software company specializing in secure, connected medical devices and healthcare applications. The company provides end-to-end security solutions—from hardware root of trust through cloud infrastructure—for safety-critical IoT deployments in consumer medical devices, connected hospitals, home healthcare, electrical stimulation and drug delivery systems, and biometric monitoring. Core product lines include AppAuth™ (device and customer authentication, remote attestation), SecureConnectivity™ (application-layer encryption across Bluetooth, NFC, LTE, Ethernet), SeamlessConnect™ (seamless device-to-gateway connectivity), and RecordAuth™ (blockchain-based data authenticity for supply chains). Thirdwayv holds FDA clearances enabling partners to meet FDA cybersecurity guidelines for medical devices and has demonstrated expertise in connected diabetes management, pacemakers, nerve stimulators, defibrillators, insulin pumps, thermometers, blood pressure monitors, glucose meters, and pulse oximeters. The company also serves connected car (OTA firmware updates, infotainment security, smartphone keyless entry) and asset-tracking markets (cold chain, surgical implant track-and-trace, hospital inventory management, retail item tracking). Leadership includes executives from Motorola, Broadcom, and GE; the advisory board includes former Qualcomm, Google, BlackBerry, and FDA officials. Thirdwayv positions itself as a "nucleus of trust" for IoT ecosystems, emphasizing security-by-design from the semiconductor level upward.